We have examined cellular inflammatory changes in the CNS following VSV infection. As early as 1 day postinfection (p.i.), astrocytes were activated in the olfactory bulb (OB). This was followed by activation of microglia, first observed in the OB at day 3 p.i. Expression of inducible nitric oxide synthase was observed in activated microglia in the OB at day 3 p.i., and increased inducible nitric oxide synthase expression coincided with decreased virus titers in tissue homogenates. Expression of major histocompatibility complex (MHC) class I molecules on astrocytes and microglial, endothelial, and ependymal cells was also rapidly induced and followed by induced expression of MHC class II molecules on astrocytes and microglial and endothelial cells. Consistent with the pattern of viral dissemination, MHC molecules were expressed temporally from the rostral-to-caudal direction. Infiltration of CD8
Although the central nervous system (CNS) has traditionally been considered an immunologically privileged site, viral infections in the CNS can nevertheless be controlled. Recent studies have shown intensive immunological infiltration in response to infections or autoimmune diseases in the CNS (8, 10, 27) , but the mechanisms mediating virus clearance and host recovery are still poorly understood. In contrast to the firmly established importance of acquired specific immunity, especially major histocompatibility complex (MHC) class I-restricted CD8 ϩ cytolytic T cells, in virus clearance in the periphery (48) , the role(s) of T cells in CNS infections is not well understood.
Intranasal instillation of vesicular stomatitis virus (VSV), a member of the rhabdovirus family (44) , into mice leads to initial infection of olfactory receptor neurons (34) and then the olfactory bulb (OB), and this is followed by acute infection of the CNS (13, 20, 28) . Virus titers peak between days 7 and 10 postinfection (p.i.). This is associated temporally with the death of approximately half of the infected mice. All surviving mice completely clear the virus from the CNS by 12 days p.i. As demonstrated in our previous work (19) , T cells (both CD4 ϩ and CD8 ϩ ) are required for clearance of VSV and host recovery. Important information about the dynamics and localization of infiltrating T cells in the VSV-infected CNS that was previously unknown was obtained in this study. Cells of the CNS lack constitutive expression of MHC molecules, but there is well-documented induction of MHC antigens (Ags) on CNS cells in mouse hepatitis virus and herpes simplex virus type 1 infections (15, 46) . Therefore, we also wanted to determine if
MHC Ags are induced on resident cells of the CNS during VSV infection.
In addition to the critical role of acquired specific immunity in the defense against CNS infections, nonspecific innate immunity, which is rapidly activated by viral infections, is also potentially of importance. Macrophages and natural killer cells have been shown to play dominant roles in controlling initial events of some peripheral viral infections (47) . Research with alpha/beta interferon (IFN-␣/␤)-deficient mice (IFN-␣/␤ receptor knockout) has also confirmed the essential role of innate immunity in resistance to intravenous VSV infection (30) . Therefore, we wanted to determine if innate immunity is elicited in the VSV-infected CNS.
Physiologically, nitric oxide (NO), first identified as an endothelial cell-relaxing factor (32) , is a highly potent biomolecule with activities in both the CNS and peripheral nervous system (5, 31) . In the CNS, NO is a neurotransmitter having many important functions, including long-term potentiation (4, 38) . NO made in peripheral macrophages has also been demonstrated to be a key component in host defense against cryptococcal, malarial, leishmanial, and herpesvirus infections (16, 23, 25, 37, 40) . Our recently published data show that NO also inhibits VSV infection in vitro (3). Since NO can be produced constitutively by neurons and endothelial cells and inducibly by activated astrocytes and microglia (5, 7, 14, 31) , it is intriguing to hypothesize that NO is a critical component of the innate immunity in controlling infections in the CNS.
We have carried out this study to further dissect the relative contributions of innate and acquired immunity in host defense against VSV infection. Specifically, we have examined (i) the kinetics of activation of resident cells of the CNS, (ii) the expression of inducible NO synthase (iNOS), (iii) the kinetics of MHC class I and II expression, and (iv) the dynamics of infiltration of T and B cells in the VSV-infected CNS. The integrity of the blood-brain barrier (BBB) following VSV infection was also investigated.
MATERIALS AND METHODS
Virus. VSV strain Indiana, serotype San Juan, was propagated in Chinese hamster ovary cells and purified over a sucrose gradient as previously described (18) .
Experimental infection of mice. Specific-pathogen-free male BALB/c AnTac mice, 5 to 7 weeks old (Taconic Farms Inc., Germantown, N.Y.), were used throughout the experiment. Mice were lightly anesthetized for 1 min in a closed container containing halothane (Halocarbon Lab, North Augusta, S.C.) and then intranasally infected with 2 ϫ 10 5 PFU of VSV in a total volume of 0.01 ml administered equally to both nostrils. Uninfected animals were used as controls. At days 1, 2, 3, 4, 8, 14, and 22 p.i., three mice were given intraperitoneally a lethal dose of 5 mg of pentobarbital sodium (Nembutal; Abbott Laboratories, North Chicago, Ill.) in serum-free RPMI medium (GIBCO, Grand Island, N.Y.). Each mouse was perfused transcardially with 20 to 30 ml of normal saline. Whole brains were removed and quick-frozen in isopentane and kept on dry ice before being stored at Ϫ70ЊC until sectioning.
Immunohistochemical reagents. The immunohistochemical reagents used are described in Table 1 , respectively). Biotin-labelled secondary antibodies (Abs) specific for the species of the first Abs and an avidin-biotinylated horseradish peroxidase complex were purchased from Vector Laboratories (Burlingame, Calif.). 3,3Ј-Diaminobenzidine and its diluting buffer were from Calbiochem Corporation (San Diego, Calif.).
Immunohistochemical staining. Brains were sectioned (20-m-thick sections) sagittally on a cryostat machine; 20 to 30 serial sections of each brain were prepared on subbed slides and stored at Ϫ70ЊC until staining. In each staining experiment, brains were removed from the Ϫ70ЊC freezer and warmed at room temperature for 10 min before being fixed in 10% neutral buffered formalin. The period of fixation varied depending on the Ags to be stained. Sections to be stained for CD4 ϩ and CD8 ϩ cells were fixed only briefly, while fixation for 5 to 10 min was generally applied to all of the other Ags. Sections were then washed twice in 0.1 M Tris-buffered saline (TBS; pH 7.6) for 10 min each time. Endogenous peroxidase activity was blocked by incubating sections in 0.3% H 2 O 2 in 0.1 M TBS for 20 min. Sections were then washed again twice in 0.1 M TBS, and background staining was blocked by preincubating sections in 1% bovine serum albumin (Fisher Scientific, Pittsburgh, Pa.) in 0.1 M TBS for 45 min. Sections were then incubated with primary Abs for specific Ags for 1 h at room temperature, but VSV staining involved overnight incubation with a primary Ab. Sections were washed again in 0.1 M TBS twice and then incubated in a biotinylated secondary Ab (ABC Kit; Vector Laboratories); this was followed by incubation in avidin plus biotinylated peroxidase for another 30 min. Sections were then incubated with 3,3Ј-diaminobenzidine in 0.01% H 2 O 2 for 5 min. Dried sections were then coverslipped with Permount (Fisher Scientific).
Assay for integrity of the BBB. Investigation of the integrity of the BBB with Evans blue staining was done essentially as previously described (6) . Briefly, 30 5-to 7-week-old male BALB/c mice were infected intranasally with 2 ϫ 10 5 PFU per mouse. At different time points p.i., three mice were injected intravenously with 200 l of 2% Evans blue (Sigma Chemical Co.). One hour later, mice were sacrificed with a lethal dose of pentobarbitol sodium (5 mg per mouse) and transcardially perfused with 5 ml of normal saline. Brains were removed, and photographs were taken. Sagittal sections of brains were also prepared to confirm penetration of the brain parenchyma by the dye.
Photomicrography. Photomicrographs were taken with an Olympus BH-2 microscope (New York/New Jersey Scientific Inc.) equipped with an automated camera system.
RESULTS
Activation of astrocytes and microglia following VSV infection. Brains of VSV-infected mice were stained for either the glial fibrillary acidic protein (GFAP), a marker of astrocytes, or Mac-1 antigen on microglial cells. Uninfected brains were similarly processed for the control and termed day 0 p.i. Astrocytosis was detected as early as day 1 p.i. and reached a peak at day 8 p.i. in the OB region (Fig. 1a) . This was found to include more numerous, larger, and heavier staining cells of the astrocyte phenotype in sections (Fig. 1b and c) . The most pronounced astrocytosis was observed to coincide with VSV antigen-positive areas including the OB, the anterior olfactory nuclei, the hippocampal formation (HC), and the parenchyma lining the fourth ventricle. Although declining at later time points, astrocytosis still remained above background levels until at least day 22 p.i. Significant microgliosis, however, was not observed until day 3 p.i. in the OB (Fig. 1d) . Mac-1-positive cells with morphologies of microglia and infiltrating macrophages were found to cluster primarily in the VSV Ag-positive areas ( Fig. 1e and f) . High numbers of Mac-1-staining microglia-macrophages were still present at day 22 p.i.
Induced expression of iNOS by astrocytes and microglia. NO is synthesized from L-arginine by a group of enzymes called NO synthases (5, 31) . While a small amount of NO is constitutively produced by neuronal or endothelial isoforms of NO synthase, large quantities of NO are produced by iNOS, which is a Ca 2ϩ -calmodulin-independent isoform of NO synthase and can be induced in many cell types, including activated astrocyte and microglial cells (7, 14) . Expression of iNOS was initially detected at day 3 p.i. in the OB (Fig. 2b and c) . At day 4 p.i., iNOS-positive cells were also found in the HC, and iNOS expression was highest at day 8 p.i. (Fig. 2a) . Most of the iNOS-positive cells were found to be phenotypically microglial cells. iNOS-positive cells were concentrated primarily in VSV Ag-positive areas. Many of the iNOS-expressing cells were still detected at day 22 p.i.
Induced expression of MHC class I and II Ags. In uninfected brains, detection of expression of MHC Ags was below the sensitivity of immunohistochemical staining. However, 2 days following VSV infection, induced expression of MHC class I was initially observed in the OB (Fig. 3a) . The strongest staining of MHC class I molecules was detected in VSV Agpositive areas. Cells with morphologies of astrocyte, microglial, endothelial, ependymal, and infiltrating inflammatory cells stained positive for MHC class I (data not shown). Induced expression of MHC class II, however, was detected beginning (Fig. 3b) . MHC class II staining was also found to be associated with VSV Ag-positive areas. Although astrocytes and endothelial, ependymal, and infiltrating inflammatory cells stained positive for MHC class II, microglial cells stained strongly positive and were encountered most frequently. The intensity of induced expression of MHC Ags decreased at later time points but still remained above the background until at least day 22 p.i.
Infiltration of VSV-infected brains by T and B cells. The dynamics of T-cell infiltration of VSV-infected brains was investigated by staining brains for CD4 and CD8, markers of functionally distinct T-cell populations. In uninfected brains, T cells (both CD4 and CD8) were present very infrequently. A rapid increase of the number of CD8
ϩ cells was found in the OB as early as 1 day after VSV infection (Fig. 4d) . In contrast,
CD4
ϩ cells were initially observed in the OB at day 4 p.i. (Fig.  4a) . Following initial infiltration, both CD4 ϩ and CD8 ϩ cells accumulated in the VSV-infected areas and reached a maximum at around days 8 to 10 p.i., when virus titers began to drop (Fig. 4b, c, e, and f) . Although T cells were rarely detected in the brain stem and fourth ventricle, where VSV Ags are detected at later stages of infection, most of the observed T cells were found in the VSV Ag-positive areas, such as the OB and HC. Until day 22 p.i., a large number of T cells were still detectable in the CNS. It is notable that CD8 ϩ cell infiltration preceded CD4 ϩ cell infiltration. This was consistent with the induction of MHC class I Ags prior to induction of MHC class II Ags in the same areas.
B-cell infiltration was also investigated by staining infected brains for immunoglobulin M and B220 Ags. Very few B cells were detected throughout the whole period of infection (Fig.  5) . Only a small number of B cells were detected after 14 days p.i., and they were found primarily in the HC.
Breakdown of the BBB following VSV infection. Some vital dyes (for example, Evans blue) which are normally excluded from the brain by the intact BBB are able to enter the brain when the integrity of the BBB is broken. This method is often used to assess simple alteration of the BBB (22) . Breakdown of the BBB was initially observed in the OB of the brain of one of three mice examined at day 6 p.i. (Fig. 6) . At day 8 p.i., the BBB was obviously broken. The intensity of staining correlated with the sickness of the animals. Only one of three mouse brains examined at day 15 p.i. had evidence of slight staining in the OB. At day 25 p.i., none of the three brains examined was stained. Sagittal sections of stained brains confirmed the penetration of the brain parenchyma by the dye. The integrity of the BBB was restored as animals recovered from the infection.
DISCUSSION
The host responses (both the resident glial cells of the CNS and infiltrating inflammatory cells) were investigated in this report. Strong astrocytosis and microgliosis were detected in the VSV Ag-positive areas (Fig. 1) . Rapid induction of iNOS was observed in activated microglial cells following VSV infec- (Fig. 2) . Induction of both MHC class I and II Ags was noticed temporally from the rostral end to the caudal end in the VSV Ag-positive areas (Fig. 3) . Immediate infiltration of CD8 ϩ T cells, followed by that of CD4 ϩ T cells, was detected in VSV-infected brains (Fig. 4) , while B-cell infiltration was noticed much later (at day 14 p.i.) and at a much lower level (Fig. 5) . Breakdown of the BBB was also observed during the infection and reached the most severe level at day 8 p.i. (Fig.  6) . The integrity of the BBB was rescued following recovery.
The importance of resident glial cells of the CNS, particularly astrocytes and microglial cells, as the CNS local innate immunity and auxiliary cells for the specific immune response has already been established (10, 17, 29) . Our data show rapid responses of astrocytes and microglial cells to VSV infection in the CNS. As early as 3 days p.i., expression of iNOS was detected in microglial cells in the OB. Increased level of iNOS expression coincided with decreased virus titers. In light of the inhibition of VSV production in vitro by NO (3), microglial production of NO might constitute one of the most important factors of the CNS innate immunity to VSV infection of neurons. Since most neurons in the CNS cannot regenerate after death, clearance of virus from neurons by a noncytolytic mechanism is advantageous. Another prominent advantage of NO as an antiviral agent is its action independent of specific immune recognition of infected cells, especially when neurons are not targets for T cells because of lack of MHC expression (21) .
In addition, both MHC class I and II Ags were induced in astrocytes and microglial cells in the VSV-infected CNS. Since . On the basis of the fact that during the course of viral infections IFN-␣/␤ is produced initially while IFN-␥ is produced relatively late, the initial induction of MHC class I Ags, followed by that of MHC class II Ags, might be explained by the initial presence of IFN-␣/␤, followed by that of IFN-␥. T cells were found infrequently in uninfected brains. Following VSV infection, however, the number of T cells was rapidly increased. This supports the view that the normal brain is under immunological surveillance (8) . Centrally involved in the first step in T-cell entry into the CNS, endothelial cells of the BBB in the VSV-infected CNS were induced to express both MHC class I and II Ags and are expected to play important roles in T-cell recruitment (1, 41) . Astrocytes and microglial cells in the VSV-infected CNS may be activated to produce T-cell-specific chemokines such as interleukin 8 and IFN-␥-inducible protein 10 (35, 42, 43) and might also play significant roles in recruiting T cells into the CNS. CD8
ϩ cells are able to bind to cultured brain microvascular endothelial cells more avidly than CD4 ϩ cells (45) . If this is also true in our system, it might also contribute to the temporal difference of infiltration between CD8 ϩ and CD4 ϩ T cells. In contrast to the importance of antibodies in clearing Sindbis virus from neurons in mice with severe combined immunodeficiency (26) , antibodies are less likely to be important in the control of VSV infection in the CNS. We did not observe accumulation of B cells in the brains of VSV-infected mice until after the mice had recovered from the infection. Passive transfer of mouse anti-VSV immune serum at the time of infection is protective (36) , but transfer of anti-VSV Abs after infection failed to protect against CNS infection (39) . This further supports our hypothesis that anti-VSV Abs are protective when they are present before or at the time of infection but not when they are present after VSV infection in the CNS has been established.
Other factors are also likely to be important in controlling VSV infection in the CNS. Although IFN-␥ does not exert an anti-VSV effect in the periphery (30) , an antiviral effect of IFN-␥ might exist in the CNS (24) . Our recent work has shown that intravenously transferred interleukin 12, a strong activator of IFN-␥ production, protected against VSV infection in the CNS (2) . Work is in progress to investigate the underlying mechanisms that promote control of and recovery from infection. 
